NDC 0074-1044 – Emrelis
Telisotuzumab Vedotin 20 mg/mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC0074-1044
Product details
- Brand name
- Emrelis
- Generic name
- Telisotuzumab Vedotin
- Labeler
- AbbVie Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761384
- Marketed since
- May 14, 2025
- Listing expires
- December 31, 2026
Active ingredients
- Telisotuzumab Vedotin 20 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0074-1044-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1044-01) / 1 mL in 1 VIAL, SINGLE-DOSE | May 14, 2025 |
Other Emrelis products
- 0074-1055 Telisotuzumab Vedotin 100 mg/mL · Injection, Powder, Lyophilized, For Solution · AbbVie Inc.